Ayden Scheim

PhD

Affiliate Scientist

Biography

Please note Dr. Scheim will not be taking any summer students.

Dr. Scheim is an Affiliate Scientist with the Centre on Drug Policy Evaluation, Li Ka Shing Knowledge Institute.

His primary appointment is as an Assistant Professor of Epidemiology in the Drexel University Dornsife School of Public Health in Philadelphia. He is also an Adjunct Assistant Professor in Epidemiology and Biostatistics at Western University. Dr. Scheim investigates the impacts of social, policy, and healthcare environments on the health of populations facing stigma. In particular, his research program involves community-engaged research with transgender populations and structurally vulnerable people who use drugs.

Recent Publications

  1. Paine, EA, Appenroth, M, Scheim, A, Goldrich, M, Giguere, R, Sandfort, T et al.. Brief Report:Availability of and Interest in Gender-Affirming Care, PrEP, and HIV Prevention Services in a Global Sample of Transmasculine Persons. J Acquir Immune Defic Syndr. 2024;97 (5):471-476. doi: 10.1097/QAI.0000000000003512. PubMed PMID:39792140 .
  2. Rutherford, LL, Castle, ER, Adams, N, Berrian, L, Jennings, L, Scheim, A et al.. Promoting trans patient autonomy in surgical preparation for phalloplasty and metoidioplasty: results from a community-based cross-sectional survey and implications for preoperative assessments. BMC Med Ethics. 2024;25 (1):155. doi: 10.1186/s12910-024-01148-3. PubMed PMID:39736610 PubMed Central PMC11686888.
  3. Jones, J, Butler, G, Woody, M, Sheets, M, Castel, AD, Kulie, P et al.. Adaptation of a HIV Prevention Mobile App for Transmasculine People: A Pilot Acceptability and Feasibility Study. Transgend Health. 2024;9 (6):573-581. doi: 10.1089/trgh.2023.0041. PubMed PMID:39735378 PubMed Central PMC11669636.
  4. Scheim, AI, Bouck, Z, Greenwald, ZR, Ling, V, Hopkins, S, Johnson, M et al.. Frequency of supervised consumption service use and acute care utilization in people who inject drugs. Drug Alcohol Depend. 2024;265 :112490. doi: 10.1016/j.drugalcdep.2024.112490. PubMed PMID:39546979 .
  5. Chakrapani, V, Santos, H, Battala, M, Gupta, S, Sharma, S, Batavia, A et al.. Access to transition-related health care among transmasculine people in India: A mixed-methods investigation. PLOS Glob Public Health. 2024;4 (10):e0003506. doi: 10.1371/journal.pgph.0003506. PubMed PMID:39471207 PubMed Central PMC11521280.
  6. Jacobsen, K, Davis, CE, Burchell, D, Rutherford, L, Lachowsky, N, Bauer, G et al.. Misgendering and the health and wellbeing of nonbinary people in Canada. Int J Transgend Health. 2024;25 (4):816-830. doi: 10.1080/26895269.2023.2278064. PubMed PMID:39465063 PubMed Central PMC11500516.
  7. Ghabrial, MA, Ferguson, T, Scheim, AI, Adams, NJ, Khatoon, M, Bauer, GR et al.. Factors associated with primary healthcare provider access among trans and non-binary immigrants, refugees, and newcomers in Canada. J Migr Health. 2024;10 :100241. doi: 10.1016/j.jmh.2024.100241. PubMed PMID:39040891 PubMed Central PMC11261874.
  8. Hallarn, J, Scheim, AI, Bauer, GR. Pre-exposure Prophylaxis Awareness and Use Among Transgender and Nonbinary Individuals in Canada. J Acquir Immune Defic Syndr. 2024;96 (4):341-349. doi: 10.1097/QAI.0000000000003443. PubMed PMID:38916428 PubMed Central PMC11195929.
  9. Perez-Brumer, A, Valdez, N, Scheim, AI. The anti-gender threat: An ethical, democratic, and scientific imperative for NIH research/ers. Soc Sci Med. 2024;351 Suppl 1 :116349. doi: 10.1016/j.socscimed.2023.116349. PubMed PMID:38825371 .
  10. Mitra, S, Bouck, Z, Larney, S, Zolopa, C, Høj, S, Minoyan, N et al.. The impact of the COVID-19 pandemic on people who use drugs in three Canadian cities: a cross-sectional analysis. Harm Reduct J. 2024;21 (1):94. doi: 10.1186/s12954-024-00996-x. PubMed PMID:38750575 PubMed Central PMC11097551.
Search PubMed

Affiliations & Other Activities

Postdoctoral Fellow, University of California San Diego